Synovial T cells from rheumatoid patients, when activated by IL-15, stimulate production of the proinflammatory cytokine, TNF-α (pages 189–195).
References
Elliott, M.J. et al. Randomised double blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344, 1105–1110 (1994).
Baumgartner, S. et al. Double-blind, placebo controlled trial of tumor necrosis factor receptor (p60) fusion protein (TNFR:Fc) in active rheumatoid arthritis (Abstr.). Arthritis Rheum. 39 (Suppl.), S74 (1996).
Zvaifler, N.J. & Firestein, G.S. Pannus and panno-cytes: Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum. 37, 783–789 (1994).
Mclnnes, I.B., Leung, B.P., Sturrock, R.D., Field, M. & Liew, F.Y. Interleukin-15 mediates T-Cell dependent regulation of tumor necrosis factor a production in rheumatoid arthritis. Nature Med. 3, 189–195 (1997).
Tagaya, Y., Bamford, R.N., DeFillipis, A.P. & Waldmann, T.A. IL-15: A pleiotropic cytokine with diverse receptor signalling pathways whose expression is controlled at multiple levels. Immunity 4, 329–336 (1996).
Kirman, I. & Nielsen, O.H. Increased numbers of interleukin-15 expressing Cells in active ulcerative colitis. Am. J. Gastroenterol. 91, 1789–1794 (1996).
Albani, S. & Carson, D.A. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol. Today 17, 466–470 (1996).
Kouskoff, V. et al. Organ-specific disease provoked by systemic autoimmunity. Cell 87, 811–822 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carson, D. Unconventional T-cell activation by IL-15 in rheumatoid arthritis. Nat Med 3, 148–149 (1997). https://doi.org/10.1038/nm0297-148
Issue Date:
DOI: https://doi.org/10.1038/nm0297-148
- Springer Nature America, Inc.